Progression of vascular calcification in uraemic patients:: can it be stopped?

被引:14
作者
Drüeke, TB
Rostand, SG
机构
[1] Hop Necker Enfants Malad, INSERM, U507, F-75743 Paris 15, France
[2] Hop Necker Enfants Malad, Serv Nephrol, F-75743 Paris 15, France
[3] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
关键词
D O I
10.1093/ndt/17.8.1365
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:1365 / 1368
页数:4
相关论文
共 32 条
[1]   Hyperphosphataemia - a silent killer of patients with renal failure? [J].
Amann, K ;
Gross, ML ;
London, GM ;
Ritz, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2085-2087
[2]   Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[3]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[4]   A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients [J].
Bleyer, AJ ;
Burke, SK ;
Dillon, M ;
Garrett, B ;
Kant, KS ;
Lynch, D ;
Rahman, SN ;
Schoenfeld, P ;
Teitelbaum, I ;
Zeig, S ;
Slatopolsky, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) :694-701
[5]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[6]   Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients [J].
Braun, J ;
Oldendorf, M ;
Moshage, W ;
Heidler, R ;
Zeitler, E ;
Luft, FC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :394-401
[7]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[8]  
Chertow GM, 1999, CLIN NEPHROL, V51, P18
[9]   Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Dillon, MA ;
Slatopolsky, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) :2907-2914
[10]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252